Simulated Effects of Policies to Reduce Diabetes Risk Among Adults With Schizophrenia Receiving Antipsychotics.
Sign Up to like & getrecommendations! Published in 2017 at "Psychiatric services"
DOI: 10.1176/appi.ps.201500485
Abstract: OBJECTIVE Second-generation antipsychotics increase the risk of diabetes and other metabolic conditions among individuals with schizophrenia. Although metabolic testing is recommended to reduce this risk, low testing rates have prompted concerns about negative health consequences… read more here.
Keywords: metabolic testing; risk; diabetes conditions; ten year ... See more keywords